MOLECULE TO CURE. FAST.
LIVE

Serial Number

90560241

Owner

Quotient Sciences Limited

Attorney

Amy Cohen Heller

Filing Date

Mar 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MOLECULE TO CURE. FAST. Trademark

Serial Number: 90560241 • Registration: 6868780

MOLECULE TO CURE. FAST. is a trademark filed by Quotient Sciences Limited on March 4, 2021. The trademark is classified under Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Quotient Sciences Limited (4 trademarks)

Trent House Mere Way, Ruddington Fields Business P

Entity Type: 98

Trademark Details

Filing Date

March 4, 2021

Registration Date

October 11, 2022

Published for Opposition

July 26, 2022

Goods & Services

Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely, manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; providing information about the results of clinical trials for pharmaceutical and biopharmaceutical products, namely, providing technical information in the field of pharmaceutical and biopharmaceutical manufacturing and testing

Contract packaging services in the nature of packaging and labeling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; packaging and labeling of products for others, namely, contract packaging services in the nature of merchandise packaging for others; storage services, namely, warehousing and temperature controlled storage of goods for others; transportation logistics services, namely, arranging transportation of goods for others; packaging articles to the order and specification of others; packaging of pharmaceutical, biopharmaceutical and clinical supplies and materials, namely, contract packaging services in the nature of pharmaceutical, biopharmaceutical and clinical supplies and materials packaging for others

Clinical research in the field of pharmacology and medical research; clinical trials for others; conducting clinical trials for others; conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science, namely, scientific research, basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; analytical services, namely, evaluation and analysis of the efficacy of pharmaceutical and biopharmaceutical products and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the fields of pharmaceuticals, biopharmaceuticals and clinical trials; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely, development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely, conducting early evaluations in the field of new pharmaceuticals and testing, inspection and research of pharmaceuticals; conducting clinical trials for others for optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others, research relating to medicine, namely, medical research, basic and clinical research in the field of pharmacology; consultancy relating to pharmaceutical and biopharmaceutical testing and screening programs in particular testing, inspection and research of pharmaceutical and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely, technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 11, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 11, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 26, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jun 21, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 17, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 13, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2022 CRFA
ASSIGNED TO LIE
Apr 29, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 26, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 29, 2021 GNRN
NON-FINAL ACTION E-MAILED
Oct 29, 2021 GNRT
NON-FINAL ACTION WRITTEN
Oct 29, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2021 NWOS
NEW APPLICATION ENTERED
Mar 8, 2021 NWAP